Abstract
EPSTEIN–BARR virus, a human herpesvirus with oncogenic potential, infects two target tissues in vivo: B lymphocytes, where the infection is largely non-productive1, and stratified squamous epithelium in which virus replication occurs2,3. The interaction with B cells, initiated through virus binding to the B-cell surface molecule CR2 (ref. 4), has been studied in vitro and the virus 'latent' genes associated with B-cell growth transformation defined5. By comparison, viral infection of epithelium remains poorly understood, reflecting the lack of an appropriate cell-culture model. Here we describe the development of such a model using as targets CR2-expressing transfected cells of two independent human epithelial lines. A high proportion of these cells bind virus and become actively infected, expressing the small EBER RNAs (small non-polyadenylated virus-coded RNAs) and the Epstein–Barr nuclear antigen 1 but not other latent proteins; thereafter, under conditions favouring epithelial differentiation, up to 30% of the cells can be induced to enter virus productive cycle with some progressing to full virus replication. We find significant differences between laboratory virus strains in their ability to infect epithelium that do not correlate with their B-cell growth-transforming activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nilsson, K., Klein, G., Henle, W. & Henle, G. Int. J. Cancer 8, 443–450 (1971).
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A. & Pagano, J. S., New Engl. J. Med. 310, 1225–1230 (1984).
Greenspan, J. S. et al. New Engl. J. Med. 313, 1564–1571 (1985).
Fingeroth, J. D. et al. Proc. natn. Acad. Sci. U.S.A. 81, 4510–4514 (1984).
Kieff, E. & Liebowitz, D. in Virology (eds Fields, B. N. et al.) 1889–1920 (Raven, New York. 1990).
Miller, G., Grogan, E., Heston, L., Robinson, J. & Smith, D. Science 212, 452–454 (1981).
Shapiro, I. M. & Volsky, D. J. Science 215, 1225–1228 (1983).
Sixbey, J. W. et al. Nature 306, 480–483 (1983).
Sixbey, J. W. et al. J. gen. Virol. 68, 805–811 (1987).
Young, L. S., Dawson, C. W., Brown, K. W. & Rickinson, A. B. Int. J. Cancer 43, 786–794 (1989).
Cepko, C. Roberts, B. & Mulligan, R. Cell 37, 1053–1062 (1984).
Ahearn, J. M. Hayward, S. D., Hickey, J. C. & Fearon, D. T. Proc. natn. Acad. Sci. U.S.A. 85, 9307–9311 (1988).
Cantaloube, J. F. et al. Eur. J. Immun. 20, 409–416 (1990).
Lerner, M. R., Andrews, N. C., Miller, G. & Steitz, J. A. Proc. natn. Acad. Sci. U.S.A. 78, 805–809 (1981).
Young, L. et al. New Engl. J. Med. 321, 1080–1085 (1989).
Rowe, M. et al. J. gen Virol. 68, 1575–1586 (1987).
Young, L. S. et al. J. Virol. 65, 2868–2874 (1991).
Pearson, G. R. et al. J. Virol. 47, 193–201 (1983).
Vroman, B., Luka, J., Rodriguez, M. & Pearson, G. R. J. Virol. 52, 107–113 (1985).
Thacher, S. M. & Rice, R. H. Cell 40, 685–695 (1985).
Rice, R. H. & Green, H. Cell 18, 681–694 (1979).
Rubin, A. L. & Rice, R. H. Cancer Res. 46, 2356–2361 (1986).
Alfieri, C., Birkenbach, M. & Kieff, E. Virology 181, 595–608 (1991).
Gilligan, K., Rajadurai, P., Resnick, L. & Raab-Traub, N. Proc. natn. Acad. Sci. U.S.A. 87, 8790–8794 (1990).
Rowe, M. et al. EMBO J. 6, 2743–2751 (1987).
Young, L. S. et al. J. gen. Virol. 69, 1051–1065 (1988).
Fahraeus, R. et al. Int. J. Cancer 42, 329–338 (1988).
Dawson, C. W., Rickinson, A. B. & Young, L. S. Nature 344, 777–780 (1990).
Fahraeus, R., Rymo L., Rhim, J. S. & Klein, G. Nature 345, 447–449 (1990).
Gubler, U. & Hoffman, B. J. Gene 25, 263–269 (1983).
Weis, J. J. et al. Proc. natn. Acad. Sci. U.S.A. 83, 5639–5643 (1986).
Moore, M. D. et al. Proc. natn. Acad. Sci. U.S.A. 84, 9194–9198 (1987).
Weis, J. J. et al. J. exp. Med. 167, 1047–1066 (1988).
Parkinson, E. K., Pera, M. F., Emmerson, A. & Gorman, P. A. Carcinogenesis 5, 1071–1077 (1984).
Milani, S., Herbst, H., Schuppan, D., Hahn, E. G. & Stein, H. Hepatology 10, 84–92 (1989).
Niedobitek, G. et al. Hum. Path. 20, 796–799 (1989).
Lin, J. et al. J. Virol. 50, 50–55 (1984).
Sample, J. et al. J. Virol. 64, 4084–4092 (1990).
Heston, L., Rabson, M., Brown, N. & Miller, G. Nature 295, 160–163 (1982).
Author information
Rights and permissions
About this article
Cite this article
Li, Q., Young, L., Niedobitek, G. et al. Epstein–Barr virus infection and replication in a human epithelial cell system. Nature 356, 347–350 (1992). https://doi.org/10.1038/356347a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/356347a0
This article is cited by
-
Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
Scientific Reports (2020)
-
Epstein–Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance
Laboratory Investigation (2010)
-
Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds
Molecular Cancer (2009)
-
Distribution and phenotype of Epstein–Barr virus-infected cells in human pharyngeal tonsils
Modern Pathology (2005)
-
Gamma herpesviruses: Pathogenesis of infection and cell signaling
Folia Microbiologica (2003)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
